Hikari Tsushin Inc’s Pfizer PFE Stock Holding History

Hikari Tsushin Inc’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,670	Closed	-$354K	–	65
2023 Q3	$354K	Hold	10,670	–	–	0.03%	50
2023 Q2	$391K	Hold	10,670	–	–	0.04%	51
2023 Q1	$435K	Hold	10,670	–	–	0.05%	50
2022 Q4	$547K	Hold	10,670	–	–	0.06%	50
2022 Q3	$467K	Hold	10,670	–	–	0.06%	45
2022 Q2	$559K	Hold	10,670	–	–	0.07%	44
2022 Q1	$552K	Hold	10,670	–	–	0.06%	41
2021 Q4	$630K	Buy	+10,670	New	+$529K	0.07%	40

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Hikari Tsushin Inc's PFE Position: Q4 2023 in Review

Hikari Tsushin Inc sold out of Pfizer (PFE) in Q4 2023, closing a stake of 10,670 shares — an estimated $354K sold.

Hikari Tsushin Inc first reported a position in PFE in Q4 2021 and held it in 8 quarters. The position peaked at $630K in Q4 2021. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

Hikari Tsushin Inc reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
Hikari Tsushin Inc sold 10,670 Pfizer shares in Q4 2023, an estimated $354K.
Hikari Tsushin Inc first reported a position in Pfizer in Q4 2021 and held it in 8 quarters.
Hikari Tsushin Inc's Pfizer position peaked at $630K in Q4 2021.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Hikari Tsushin Inc's 13F filing for Q4 2023, filed 8 Feb 2024.